Cat. # | Size | Qty. | Price |
---|---|---|---|
72782S | 1 Kit (100 assays) |
|
Product Includes | Quantity (with Count) | ||||
---|---|---|---|---|---|
7-AAD Viability Dye | 2 x 50 µl | ||||
CFSE Stock Solution | 1 x 100 µl | ||||
Cell-Based Assay Buffer Tablet | 1 x 4 ea |
Product Information
Supplied Reagents:
NOTE: The recommended protocol labels cells with CFSE brightly enough to distinguish labeled and unlabeled cells, but dimly enough not to bleed into other channels. However, should brighter staining be desired, BSA can be omitted from the CFSE Staining Solution preparation.
Additional Reagents (Not Supplied):
NOTE: To properly analyze the data, the following control target cell groups are needed to set up the flow cytometer and compensation:
Effector:Target Ratio | Effector Cell Suspension | Target Cell Suspension | Target Cell Medium | Final Volume |
---|---|---|---|---|
0 | 0 ml | 1.5 ml | 0 ml | 1.5 ml |
6.25:1 | 0.125 ml | 1 ml | 0.375 ml | 1.5 ml |
12.5:1 | 0.25 ml | 1 ml | 0.25 ml | 1.5 ml |
25:1 | 0.5 ml | 1 ml | 0 ml | 1.5 ml |
NOTE: If additional surface markers are to be assayed, staining can be inserted at this point in the protocol.
Problem | Possible Causes | Recommended Solutions |
---|---|---|
Low signal of CFSE |
|
|
No difference in cytotoxicity among different effector cell to target cell ratios |
|
|
Posted February 2020
Protocol Id: 1964
Cytolytic assays are routinely used to interrogate immune effector cell function. In order to interrogate immune effector cell cytolytic activity in a heterogeneous cell population of effector and target cells, it is imperative to be able to discriminate between effector and target cell populations with distinct phenotypes. As such, this kit is designed to label live target cells with the membrane permeable fluorescent dye CFSE prior to coculture with unlabelled effector cells, thus permitting a clear separation between live effector and target cells. After incubation of live effector and target cells, the DNA intercalating dye 7-AAD is added to label dying target cells with compromised plasma membranes. By using dyes with distinct spectral properties, a clear separation between four cell populations can be obtained using flow cytometry: live target cells, dead target cells, live effector cells, and dead effector cells (1).
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.